Trustcore Financial Services, LLC Clearside Biomedical, Inc. Transaction History

Trustcore Financial Services, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 30, 2021	SELL	$2.24 - $4.25 $60,480 - $114,750	-27,000 Closed	0 $0
Q4 2020 Feb 04, 2021	BUY	$1.32 - $2.74 $33,000 - $68,500	25,000 Added 1250.0%	27,000 $74,000
Q2 2019 Jul 25, 2019	BUY	$0.97 - $1.42 $1,940 - $2,840	2,000 New	2,000 $2,000
Q4 2018 Feb 05, 2019	SELL	$1.0 - $6.12 $16,585 - $101,500	-16,585 Closed	0 $0
Q3 2018 Nov 09, 2018	BUY	$6.03 - $11.24 $12,060 - $22,480	2,000 Added 13.71%	16,585 $102,000
Q2 2018 Jul 30, 2018	BUY	$8.91 - $14.54 $95,782 - $156,305	10,750 Added 280.31%	14,585 $156,000
Q1 2018 May 04, 2018	BUY	$5.57 - $14.28 $3,342 - $8,568	600 Added 18.55%	3,835 $41,000
Q4 2017 Feb 09, 2018	BUY	$5.78 - $9.12 $18,698 - $29,503	3,235	3,235 $23,000

12.2M

54.7K

50.7K

Ticker CLSD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,190,700
Market Cap $56.6M
Description
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...

Get notified when there are updates to the investment portfolio of Trustcore Financial Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Trustcore Financial Services, LLC with notifications on news.